Purac to build new plant for biomedical resorbable polymers in the USA
Purac announces the investment in a new manufacturing facility for its biomedical polymers. The plant is meant to support the growing resorbable polymers business of Purac Biomaterials. Purac currently operates a plant for biomedical polymers in The Netherlands. This second facility will be built in the USA. The investment for this new plant will be EUR 15 million. The construction of the facility will start in 2011 and is expected to be completed before the end of the year.
Arno van de Ven, Purac Vice President Chemicals & Pharma comments: “This represents an important step in the biomedical polymer business and shows Purac’s continued commitment to this market. It provides us with the capability to support the growth of our existing and new business partners.”
Besides an increase in the production capacity, the new facility will bring Purac Biomaterials more flexibility and a more balanced presence in its global markets.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Camille_Guérin

The weight of pollution: exposure linked to obesity - Chronic exposure to environmental pollutants found to increase risk of cardiovascular disease

Merck Opens New € 29 Million Biologics Testing Center in Shanghai - First-of-its-kind facility for Merck in China to meet local demand

LUMiFuge® | Stability analyzers | LUM
Testing the Efficacy of New Gene Therapies More Efficiently

Happy hour for time-resolved crystallography - Researchers simplify time-resolved X-ray crystallography

Grb10 offers a potential new approach for treating obesity - The fat tissue-brain connection

Startup revolutionizes diagnostics in dermatology - Dermagnostix closes seven-figure seed round

Scientists produce clearest-ever images of enzyme that plays key roles in aging, cancer

How Colon Cancer Hides from the Immune System - Researchers Identify New Targets for Immunotherapy in Colon Cancer
